Search

Hung D. Le

Examiner (ID: 9547, Phone: (571)270-1404 , Office: P/2161 )

Most Active Art Unit
2161
Art Unit(s)
2161
Total Applications
1282
Issued Applications
1101
Pending Applications
84
Abandoned Applications
117

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7074341 [patent_doc_number] => 20050147609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Use of anti-IL-17 antibody for the treatment of cartilage damaged by osteoarthritis' [patent_app_type] => utility [patent_app_number] => 10/948780 [patent_app_country] => US [patent_app_date] => 2004-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 47336 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20050147609.pdf [firstpage_image] =>[orig_patent_app_number] => 10948780 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/948780
Use of anti-IL-17 antibody for the treatment of cartilage damaged by osteoarthritis Sep 22, 2004 Abandoned
Array ( [id] => 7103873 [patent_doc_number] => 20050106599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Complementary DNAs' [patent_app_type] => utility [patent_app_number] => 10/930331 [patent_app_country] => US [patent_app_date] => 2004-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 60113 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20050106599.pdf [firstpage_image] =>[orig_patent_app_number] => 10930331 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/930331
Complementary DNAs Aug 29, 2004 Abandoned
Array ( [id] => 7089032 [patent_doc_number] => 20050009145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Mammalian receptor proteins; related reagents and methods' [patent_app_type] => utility [patent_app_number] => 10/924667 [patent_app_country] => US [patent_app_date] => 2004-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 34493 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009145.pdf [firstpage_image] =>[orig_patent_app_number] => 10924667 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/924667
Mammalian receptor proteins; related reagents and methods Aug 22, 2004 Abandoned
Array ( [id] => 6971754 [patent_doc_number] => 20050037464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Prokineticin polypeptides, related compositions and methods' [patent_app_type] => utility [patent_app_number] => 10/912907 [patent_app_country] => US [patent_app_date] => 2004-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15198 [patent_no_of_claims] => 103 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20050037464.pdf [firstpage_image] =>[orig_patent_app_number] => 10912907 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/912907
Prokineticin polypeptides, related compositions and methods Aug 5, 2004 Abandoned
Array ( [id] => 7345453 [patent_doc_number] => 20040247598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Use of il-18 inhibitors in hypersensitivity disorders' [patent_app_type] => new [patent_app_number] => 10/486612 [patent_app_country] => US [patent_app_date] => 2004-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16290 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20040247598.pdf [firstpage_image] =>[orig_patent_app_number] => 10486612 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/486612
Use of il-18 inhibitors in hypersensitivity disorders Jul 12, 2004 Abandoned
Array ( [id] => 7428266 [patent_doc_number] => 20040265966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Secreted and transmebrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/884091 [patent_app_country] => US [patent_app_date] => 2004-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 82019 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0265/20040265966.pdf [firstpage_image] =>[orig_patent_app_number] => 10884091 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/884091
Secreted and transmebrane polypeptides and nucleic acids encoding the same Jun 30, 2004 Abandoned
Array ( [id] => 7345445 [patent_doc_number] => 20040247597 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Method of treating atherosclerosis and other inflammatory diseases' [patent_app_type] => new [patent_app_number] => 10/482269 [patent_app_country] => US [patent_app_date] => 2004-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10274 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20040247597.pdf [firstpage_image] =>[orig_patent_app_number] => 10482269 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/482269
Method of treating atherosclerosis and other inflammatory diseases Jun 29, 2004 Abandoned
Array ( [id] => 7182828 [patent_doc_number] => 20050191303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-01 [patent_title] => 'Interleukin-18-binding protein' [patent_app_type] => utility [patent_app_number] => 10/876572 [patent_app_country] => US [patent_app_date] => 2004-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10644 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20050191303.pdf [firstpage_image] =>[orig_patent_app_number] => 10876572 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/876572
Interleukin-18-binding protein Jun 27, 2004 Abandoned
Array ( [id] => 7082649 [patent_doc_number] => 20050048029 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Il-17 like molecules and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/870711 [patent_app_country] => US [patent_app_date] => 2004-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 46794 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048029.pdf [firstpage_image] =>[orig_patent_app_number] => 10870711 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/870711
Il-17 like molecules and uses thereof Jun 16, 2004 Abandoned
Array ( [id] => 6990850 [patent_doc_number] => 20050089887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Novel human ion channel proteins' [patent_app_type] => utility [patent_app_number] => 10/862110 [patent_app_country] => US [patent_app_date] => 2004-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23744 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20050089887.pdf [firstpage_image] =>[orig_patent_app_number] => 10862110 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/862110
Novel human ion channel proteins Jun 3, 2004 Abandoned
Array ( [id] => 5608487 [patent_doc_number] => 20060270003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'IL-17A/F heterologous polypeptides and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 10/860824 [patent_app_country] => US [patent_app_date] => 2004-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 62316 [patent_no_of_claims] => 75 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20060270003.pdf [firstpage_image] =>[orig_patent_app_number] => 10860824 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/860824
IL-17A/F heterologous polypeptides and therapeutic uses thereof Jun 1, 2004 Abandoned
Array ( [id] => 466038 [patent_doc_number] => 07235238 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-06-26 [patent_title] => 'Antibodies that bind receptor protein designated 2F1' [patent_app_type] => utility [patent_app_number] => 10/857664 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13181 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/235/07235238.pdf [firstpage_image] =>[orig_patent_app_number] => 10857664 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/857664
Antibodies that bind receptor protein designated 2F1 May 27, 2004 Issued
Array ( [id] => 7250183 [patent_doc_number] => 20050074427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-07 [patent_title] => 'IL-17 like molecules and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/855810 [patent_app_country] => US [patent_app_date] => 2004-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 46767 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0074/20050074427.pdf [firstpage_image] =>[orig_patent_app_number] => 10855810 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/855810
IL-17 like molecules and uses thereof May 26, 2004 Abandoned
Array ( [id] => 7061090 [patent_doc_number] => 20050003451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'IL-17 like molecules and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/846352 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 46835 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20050003451.pdf [firstpage_image] =>[orig_patent_app_number] => 10846352 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/846352
IL-17 like molecules and uses thereof May 12, 2004 Abandoned
Array ( [id] => 4939389 [patent_doc_number] => 20080076708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Active Variants of the Il-18 Binding Protein and Medical Uses Thereof' [patent_app_type] => utility [patent_app_number] => 10/556417 [patent_app_country] => US [patent_app_date] => 2004-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10320 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076708.pdf [firstpage_image] =>[orig_patent_app_number] => 10556417 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/556417
Active Variants of the Il-18 Binding Protein and Medical Uses Thereof May 10, 2004 Abandoned
Array ( [id] => 5601800 [patent_doc_number] => 20060292145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Human antihuman interleukin-18 antibody, fragment thereof and method for using same' [patent_app_type] => utility [patent_app_number] => 10/555074 [patent_app_country] => US [patent_app_date] => 2004-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16280 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20060292145.pdf [firstpage_image] =>[orig_patent_app_number] => 10555074 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/555074
Human anti-human interleukin-18 antibody, fragment thereof and method for using same Apr 29, 2004 Issued
Array ( [id] => 7465931 [patent_doc_number] => 20040198642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Enhancement of GLP-2 activity' [patent_app_type] => new [patent_app_number] => 10/829201 [patent_app_country] => US [patent_app_date] => 2004-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8843 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198642.pdf [firstpage_image] =>[orig_patent_app_number] => 10829201 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/829201
Enhancement of GLP-2 activity of suppressing appetite Apr 21, 2004 Issued
Array ( [id] => 7461458 [patent_doc_number] => 20040197856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/473391 [patent_app_country] => US [patent_app_date] => 2004-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 23738 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20040197856.pdf [firstpage_image] =>[orig_patent_app_number] => 10473391 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/473391
Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof Apr 7, 2004 Abandoned
Array ( [id] => 7010803 [patent_doc_number] => 20050064519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Methods of using GST-Omega-2' [patent_app_type] => utility [patent_app_number] => 10/818204 [patent_app_country] => US [patent_app_date] => 2004-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7084 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20050064519.pdf [firstpage_image] =>[orig_patent_app_number] => 10818204 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/818204
Methods of using GST-Omega-2 Apr 4, 2004 Abandoned
Array ( [id] => 7677662 [patent_doc_number] => 20040152164 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => '62 human secreted proteins' [patent_app_type] => new [patent_app_number] => 10/798512 [patent_app_country] => US [patent_app_date] => 2004-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 176888 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152164.pdf [firstpage_image] =>[orig_patent_app_number] => 10798512 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/798512
62 human secreted proteins Mar 11, 2004 Abandoned
Menu